2016
DOI: 10.1007/s11764-016-0559-y
|View full text |Cite
|
Sign up to set email alerts
|

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208

Abstract: Purpose We describe 7 years of follow-up for the energy/vitality outcome in early-stage Hodgkin's disease patients treated on a randomized clinical trial that compared subtotal lymphoid irradiation (STLI) with combined modality treatment (CMT) (SWOG 9133). Survivorship research questions involved the extent to which symptoms/side effects endured over a follow-up period of 7 years for this early-stage patient group. Methods Two hundred thirty-nine patients participated in the quality of life (QOL) companion s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 31 publications
0
1
0
1
Order By: Relevance
“…e Cancer Rehabilitation Evaluation System-Short Form (CARES-SF) [9] was used to evaluate the quality of life of patients. e scale contained 59 items in total, and each item was scored using a 5-level scoring method.…”
Section: Comparative Indicesmentioning
confidence: 99%
“…e Cancer Rehabilitation Evaluation System-Short Form (CARES-SF) [9] was used to evaluate the quality of life of patients. e scale contained 59 items in total, and each item was scored using a 5-level scoring method.…”
Section: Comparative Indicesmentioning
confidence: 99%
“…Patients were evaluated annually, and with increasing years after treatment, the differences between the groups flattened, with the remaining patients not experiencing a long-term effect of fatigue regardless of the type of therapy. A decrease in vitality was more severe with CMT, but after the first year, vitality scores were similar between the two treatment groups [19]. The evaluation tool used was SF-36.…”
Section: Quality Of Lifementioning
confidence: 99%
“…Kesehatan secara umum dan vitalitas dipengaruhi oleh pengalaman seseorang dalam menjalani sakit dan dukungan keluarga (Guérin, 2012). Semakin lama pasien manjalani kemoterapi maka pasien mampu beradaptasi dan mempertahankan kualitas hidup pasien (Moinpour et al, 2017).…”
Section: Kesehatan Secara Umum Dan Vitalitasunclassified